Cambridge Investment Research Advisors, Inc. Epizyme, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
About Epizyme, Inc.
- Ticker EPZM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 168,364,992
- Market Cap $247M